EarningsQ2 2023 Earnings Report

Altimmune (ALT1) Q2 2023 Earnings Report

0 Followers

MX:ALT1 Q2 2023 EPS Results

Actual EPS-$5.76

Consensus EPS-$8.37

Beat/MissBeat by +$2.61

One Year Ago EPS-$7.56

Actual Revenue$108.03K

Expected Revenue$54.01K

Beat/MissBeat by +$54.01K

YoY Revenue Growth-25.00%

QuarterQ2 2023

Date08/10/2023

TimeBefore Open

Conference CallThursday, August 10, 2023

MX:ALT1 Upcoming Earnings

Altimmune's next earnings date is estimated for November 10, 2026, based on past reporting schedules.

MX:ALT1 Q2 2023 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 10, 2026	2026 (Q3)	-2.38 / -	-3.781	―
Aug 12, 2026	2026 (Q2)	-2.48 / -2.16	-4.861	55.56% (+2.70)
May 13, 2026	2026 (Q1)	-4.36 / -3.24	-4.681	30.77% (+1.44)
Mar 05, 2026	2025 (Q4)	-4.29 / -4.86	-5.942	18.18% (+1.08)
Nov 06, 2025	2025 (Q3)	-4.90 / -3.78	-5.762	34.38% (+1.98)
Aug 12, 2025	2025 (Q2)	-6.05 / -4.86	-6.302	22.86% (+1.44)
May 13, 2025	2025 (Q1)	-6.34 / -4.68	-6.122	23.53% (+1.44)
Feb 27, 2025	2024 (Q4)	-5.98 / -5.94	-9.723	38.89% (+3.78)
Nov 12, 2024	2024 (Q3)	-6.43 / -5.76	-7.022	17.95% (+1.26)
Aug 08, 2024	2024 (Q2)	-6.28 / -6.30	-5.762	-9.37% (-0.54)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed